Here are three things to know:
1. The patent covers Kuros’ technology for the production of osteoinductive calcium phosphates, which feature a surface topography designed to instruct stem cells and osteoprogenitor cells to differentiate into bone-forming cells.
2. The company is forming a patent portfolio and submitting patent applications to protects its proprietary MagnetOs product family.
3. MagnetOs is a bone graft substitute designed to fill bony voids or gaps to promote the bone formation at the implantation site.
More articles on biologics:
LifeNet Health unveils moldable osteobiologic solution for spine: 5 insights
ApoGraft-enriched stem cells show positive results in orthopedic application: 3 notes
Kuros Biosciences seeks spinal fusion product expansion: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
